ARTICLE | Politics & Policy
CancerLinQ announces collaborations with FDA, NCI
June 1, 2017 9:57 PM UTC
The CancerLinQ LLC data analysis subsidiary of the American Society of Clinical Oncology (ASCO) revealed two data sharing collaborations with FDA and NCI to examine real-world use of cancer treatments and inform patient care, cancer surveillance, and future regulatory decision-making.
The CancerLinQ research and analytics platform, created by ASCO to help guide cancer treatment decisions and measure quality and performance, has more than 1 million cancer patient records (see BioCentury Extra, Nov. 12, 2013)...